{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T04:55:24Z","timestamp":1783400124741,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Immunopharmacology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.intimp.2024.112988","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T12:14:02Z","timestamp":1724933642000},"page":"112988","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Interferon regulatory factor 1 mediated inhibition of Treg cell differentiation induces maternal-fetal immune imbalance in preeclampsia"],"prefix":"10.1016","volume":"141","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1313-6372","authenticated-orcid":false,"given":"Yue","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglong","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanying","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6265-5860","authenticated-orcid":false,"given":"Yongqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.intimp.2024.112988_b0005","doi-asserted-by":"crossref","DOI":"10.1111\/aji.13503","article-title":"A review of key cytokines based on gene polymorphism in the pathogenesis of pre-eclampsia","volume":"87","author":"Guan","year":"2022","journal-title":"Am. J. Reprod. Immunol."},{"issue":"11","key":"10.1016\/j.intimp.2024.112988_b0010","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.3390\/cells12111545","article-title":"Modulation of NRF2\/KEAP1 signaling in preeclampsia","volume":"12","author":"Tossetta","year":"2023","journal-title":"Cells"},{"key":"10.1016\/j.intimp.2024.112988_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2014.00244","article-title":"Innate immune system and preeclampsia","volume":"5","author":"Perez-Sepulveda","year":"2014","journal-title":"Front. Immunol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112988_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/jcmm.12715","article-title":"Amniotic mesenchymal cells from pre-eclamptic placentae maintain immunomodulatory features as healthy controls","volume":"20","author":"Pianta","year":"2016","journal-title":"J. Cell Mol. Med."},{"issue":"3","key":"10.1016\/j.intimp.2024.112988_b0025","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3390\/biology13030165","article-title":"The \u201cBad Father\u201d paternal role in biology of pregnancy and in birth outcome","volume":"13","author":"Giannubilo","year":"2024","journal-title":"Biology"},{"issue":"3","key":"10.1016\/j.intimp.2024.112988_b0030","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ygyno.2017.04.019","article-title":"The immune response in pregnancy and in cancer is active and supportive of placental and tumor cell growth not their destruction","volume":"145","author":"Beaman","year":"2017","journal-title":"Gynecologic Oncology"},{"issue":"8","key":"10.1016\/j.intimp.2024.112988_b0035","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1038\/nri.2017.64","article-title":"The unique immunological and microbial aspects of pregnancy","volume":"17","author":"Mor","year":"2017","journal-title":"Nat. Rev. Immunol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112988_b0040","doi-asserted-by":"crossref","first-page":"356","DOI":"10.3892\/etm.2022.11283","article-title":"Relationship of interferon regulator factor 5 and interferon-\u03b3 with missed abortion","volume":"23","author":"Herki\u0307loglu","year":"2022","journal-title":"Exp. Ther. Med."},{"key":"10.1016\/j.intimp.2024.112988_b0045","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.canlet.2021.03.002","article-title":"Interferon regulatory factor 1(IRF-1) activates anti-tumor immunity via CXCL10\/CXCR3 axis in hepatocellular carcinoma (HCC)","volume":"506","author":"Yan","year":"2021","journal-title":"Cancer Lett."},{"issue":"1","key":"10.1016\/j.intimp.2024.112988_b0050","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.2017.389","article-title":"Interferon regulatory factor 1 priming of tumour-derived exosomes enhances the antitumour immune response","volume":"118","author":"Yang","year":"2018","journal-title":"Br. J. Cancer"},{"issue":"5","key":"10.1016\/j.intimp.2024.112988_b0055","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1002\/ijc.31083","article-title":"Role of interferon regulatory factor 1 in governing treg depletion, Th1 polarization, inflammasome activation and antitumor efficacy of cyclophosphamide","volume":"142","author":"Buccione","year":"2018","journal-title":"Int. J. Cancer"},{"issue":"10","key":"10.1016\/j.intimp.2024.112988_b0060","doi-asserted-by":"crossref","first-page":"5028","DOI":"10.7150\/thno.56141","article-title":"Distinct placental molecular processes associated with early-onset and late-onset preeclampsia","volume":"11","author":"Ren","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.intimp.2024.112988_b0065","doi-asserted-by":"crossref","unstructured":"Review: IRF-1 as a Negative Regulator of Cell Proliferation, 22(1) (2002) 39-47.","DOI":"10.1089\/107999002753452647"},{"key":"10.1016\/j.intimp.2024.112988_b0070","doi-asserted-by":"crossref","unstructured":"Interferon Regulatory Factors in Hematopoietic Cell Differentiation and Immune Regulation, 29(12) (2009) 765-780.","DOI":"10.1089\/jir.2009.0030"},{"issue":"1","key":"10.1016\/j.intimp.2024.112988_b0075","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu. Rev. Immunol."},{"issue":"2","key":"10.1016\/j.intimp.2024.112988_b0080","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1006\/scbi.2000.0310","article-title":"The interferon regulatory factors and oncogenesis","volume":"10","author":"Tanaka","year":"2000","journal-title":"Semin. Cancer Biol."},{"issue":"1","key":"10.1016\/j.intimp.2024.112988_b0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/ni1538","article-title":"The contribution of transcription factor IRF1 to the interferon-\u03b3\u2013interleukin 12 signaling axis and TH1 versus TH-17 differentiation of CD4+ T cells","volume":"9","author":"Kano","year":"2008","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.intimp.2024.112988_b0090","doi-asserted-by":"crossref","unstructured":"F. Chalmin, E. Humblin, F. Ghiringhelli, F. V\u00e9gran, Chapter One - Transcriptional Programs Underlying Cd4 T Cell Differentiation and Functions, in: L. Galluzzi, N.-P. Rudqvist (Eds.), International Review of Cell and Molecular Biology, Academic Press2018, pp. 1-61.","DOI":"10.1016\/bs.ircmb.2018.07.002"},{"issue":"3","key":"10.1016\/j.intimp.2024.112988_b0095","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.4049\/jimmunol.181.3.1673","article-title":"IFN regulatory factor-1 negatively regulates CD4+CD25+ regulatory T cell differentiation by repressing Foxp3 expression1","volume":"181","author":"Fragale","year":"2008","journal-title":"J. Immunol."},{"issue":"3","key":"10.1016\/j.intimp.2024.112988_b0100","first-page":"1759","article-title":"IRF1 association with tumor immune microenvironment and use as a diagnostic biomarker for colorectal cancer recurrence","volume":"19","author":"Wu","year":"2020","journal-title":"Oncol. Lett."},{"issue":"52","key":"10.1016\/j.intimp.2024.112988_b0105","doi-asserted-by":"crossref","first-page":"37256","DOI":"10.1074\/jbc.M113.527531","article-title":"Histone deacetylase sirtuin 1 deacetylates IRF1 protein and programs dendritic cells to control Th17 protein differentiation during autoimmune inflammation *","volume":"288","author":"Yang","year":"2013","journal-title":"J. Biol. Chem."},{"issue":"10","key":"10.1016\/j.intimp.2024.112988_b0110","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1172\/JCI122182","article-title":"Regulatory T cells in embryo implantation and the immune response to pregnancy","volume":"128","author":"Robertson","year":"2018","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.intimp.2024.112988_b0115","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2019.00478","article-title":"Therapeutic potential of regulatory T cells in preeclampsia\u2014opportunities and challenges","volume":"10","author":"Robertson","year":"2019","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.intimp.2024.112988_b0120","doi-asserted-by":"crossref","first-page":"5106","DOI":"10.1002\/jcp.27315","article-title":"The imbalance of Th17\/Treg axis involved in the pathogenesis of preeclampsia","volume":"234","author":"Eghbal-Fard","year":"2019","journal-title":"J. Cell. Physiol."},{"issue":"5","key":"10.1016\/j.intimp.2024.112988_b0125","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1111\/tan.14055","article-title":"Got your mother in a whirl: the role of maternal T cells and myeloid cells in pregnancy","volume":"96","author":"Eikmans","year":"2020","journal-title":"Hla"},{"issue":"1","key":"10.1016\/j.intimp.2024.112988_b0130","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1111\/imm.12595","article-title":"The T helper type 17\/regulatory T cell paradigm in pregnancy","volume":"148","author":"Figueiredo","year":"2016","journal-title":"Immunology"},{"issue":"3","key":"10.1016\/j.intimp.2024.112988_b0135","first-page":"209","article-title":"Plasma albumin level as an indicator of severity of preeclampsia","volume":"31","author":"Gojnic","year":"2004","journal-title":"Clin. Exp. Obstet Gynecol."},{"issue":"6","key":"10.1016\/j.intimp.2024.112988_b0140","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/j.1447-0756.2010.01296.x","article-title":"Clinical significance of serum albumin level in pregnancy-related hypertension","volume":"36","author":"Seong","year":"2010","journal-title":"J. Obstet. Gynaecol. Res."},{"issue":"3","key":"10.1016\/j.intimp.2024.112988_b0145","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/ibd\/izaa200","article-title":"IRF5 acts as a potential therapeutic marker in inflammatory bowel diseases","volume":"27","author":"Yang","year":"2021","journal-title":"Inflamm. Bowel Dis."},{"issue":"6","key":"10.1016\/j.intimp.2024.112988_b0150","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/ibd.21476","article-title":"IRF4 regulates IL-17A promoter activity and controls ROR\u03b3t-dependent Th17 colitis in vivo","volume":"17","author":"Mudter","year":"2011","journal-title":"Inflamm. Bowel Dis."},{"key":"10.1016\/j.intimp.2024.112988_b0155","doi-asserted-by":"crossref","unstructured":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222, 135(6) (2020) e237-e260.","DOI":"10.1097\/AOG.0000000000003891"},{"issue":"4","key":"10.1016\/j.intimp.2024.112988_b0160","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/j.apsb.2020.12.018","article-title":"Biological drug and drug delivery-mediated immunotherapy","volume":"11","author":"Xiao","year":"2021","journal-title":"Acta Pharmaceutica Sinica B"},{"issue":"6","key":"10.1016\/j.intimp.2024.112988_b0165","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1161\/HYPERTENSIONAHA.114.04892","article-title":"Regulatory T cells ameliorate intrauterine growth retardation in a transgenic rat model for preeclampsia","volume":"65","author":"Przybyl","year":"2015","journal-title":"Hypertension"}],"container-title":["International Immunopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1567576924015091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,8]],"date-time":"2024-11-08T17:37:01Z","timestamp":1731087421000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1567576924015091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":33,"alternative-id":["S1567576924015091"],"URL":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112988","relation":{},"ISSN":["1567-5769"],"issn-type":[{"value":"1567-5769","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interferon regulatory factor 1 mediated inhibition of Treg cell differentiation induces maternal-fetal immune imbalance in preeclampsia","name":"articletitle","label":"Article Title"},{"value":"International Immunopharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.intimp.2024.112988","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"112988"}}